Form 4: XOMA Royalty Corp Director Heather Franklin Receives Equity Grant

XOMA Royalty Corp's Director, Heather L. Franklin, was granted 5,971 restricted stock units (RSUs) on May 21, 2025, as part of her compensation.

Summary

• Heather L. Franklin, a Director of XOMA Royalty Corp, was granted 5,971 restricted stock units (RSUs).
• The transaction occurred on May 21, 2025.
• Each RSU represents the right to receive one share of common stock of the Company.
• The RSUs will vest on the first anniversary of the grant date, subject to Ms. Franklin's continued service to the Company through such vesting date.
• The acquisition price for these RSUs was $0.
• Following this transaction, Ms. Franklin beneficially owns 5,971 shares directly.

Sentiment

Score: 6

Explanation: The filing reports a standard equity grant to a director, which is a neutral to slightly positive event as it aligns the director's interests with shareholders, but does not indicate significant operational or financial news.

Positives

• The grant of 5,971 restricted stock units (RSUs) to Director Heather L. Franklin aligns her interests with those of shareholders, as the value of her compensation is tied to the company's stock performance.
• Equity compensation is a common practice to attract and retain qualified board members.

Risks

• The vesting of the restricted stock units is contingent upon the reporting person's continued service to the Company, meaning the shares could be forfeited if service ceases before the vesting date.

Future Outlook

The 5,971 restricted stock units granted to Director Heather L. Franklin are expected to vest on May 21, 2026, provided she continues her service to XOMA Royalty Corp until that date.

Industry Context

The granting of restricted stock units (RSUs) to directors is a common and widely accepted practice across various industries, including the biotechnology and royalty sectors, to incentivize long-term commitment and align leadership interests with shareholder value creation.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as part of director compensation is a standard practice in corporate governance, consistent with compensation structures observed in companies like Royalty Pharma plc (RPRX) or other biotech royalty firms, which often use equity to align director incentives with long-term company performance.
• The vesting schedule, typically one year for such grants, is also a common industry benchmark for director equity awards, ensuring continued engagement.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to a director can be considered a related party transaction, as it involves compensation to an insider. However, such transactions are standard practice and typically governed by established compensation policies approved by independent board committees.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Continued service of Heather L. Franklin as a Director of XOMA Royalty Corp.
• Vesting of the 5,971 restricted stock units on May 21, 2026.

Key Dates

Keywords

XOMA Royalty Corp, XOMA, Form 4, Restricted Stock Units, RSU, Equity Compensation, Director Compensation, Insider Transaction, Beneficial Ownership, Corporate Governance